vs
Protalix BioTherapeutics, Inc.（PLX）与Terra Property Trust, Inc.（TPTA）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Terra Property Trust, Inc.的1.3倍（$9.1M vs $7.1M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -150.2%，领先89.9%），Terra Property Trust, Inc.同比增速更快（-37.4% vs -49.9%），过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高（-6.7% vs -31.3%）
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
该条目描述的是位于华盛顿哥伦比亚特区市中心纽约大道与西北15街交汇处的历史银行建筑，曾被称为国家安全储蓄信托公司建筑，是当地具有历史意义的地标建筑。
PLX vs TPTA — 直观对比
营收规模更大
PLX
是对方的1.3倍
$7.1M
营收增速更快
TPTA
高出12.6%
-49.9%
净利率更高
PLX
高出89.9%
-150.2%
两年增速更快
PLX
近两年复合增速
-31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.1M | $7.1M |
| 净利润 | $-5.5M | $-10.6M |
| 毛利率 | 49.4% | — |
| 营业利润率 | -51.1% | -48.8% |
| 净利率 | -60.3% | -150.2% |
| 营收同比 | -49.9% | -37.4% |
| 净利润同比 | -184.8% | 32.0% |
| 每股收益（稀释后） | $-0.06 | $-0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLXTPTA
| Q4 25 | $9.1M | $7.1M | ||
| Q3 25 | $17.9M | $7.3M | ||
| Q2 25 | $15.7M | $8.6M | ||
| Q1 25 | $10.1M | $12.5M | ||
| Q4 24 | $18.2M | $11.3M | ||
| Q3 24 | $18.0M | $12.2M | ||
| Q2 24 | $13.5M | $11.2M | ||
| Q1 24 | — | $15.0M |
净利润PLXTPTA
| Q4 25 | $-5.5M | $-10.6M | ||
| Q3 25 | $2.4M | $-6.7M | ||
| Q2 25 | $164.0K | $-9.2M | ||
| Q1 25 | $-3.6M | $-1.3M | ||
| Q4 24 | $6.5M | $-15.6M | ||
| Q3 24 | $3.2M | $-7.8M | ||
| Q2 24 | $-2.2M | $-7.5M | ||
| Q1 24 | — | $-6.2M |
毛利率PLXTPTA
| Q4 25 | 49.4% | — | ||
| Q3 25 | 53.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 78.7% | — | ||
| Q3 24 | 53.4% | — | ||
| Q2 24 | 29.8% | — | ||
| Q1 24 | — | — |
营业利润率PLXTPTA
| Q4 25 | -51.1% | -48.8% | ||
| Q3 25 | 11.9% | 6.7% | ||
| Q2 25 | 7.5% | -28.4% | ||
| Q1 25 | -41.0% | 32.8% | ||
| Q4 24 | 39.6% | -72.3% | ||
| Q3 24 | 22.2% | 54.1% | ||
| Q2 24 | -18.0% | 6.3% | ||
| Q1 24 | — | 32.0% |
净利率PLXTPTA
| Q4 25 | -60.3% | -150.2% | ||
| Q3 25 | 13.2% | -92.4% | ||
| Q2 25 | 1.0% | -106.5% | ||
| Q1 25 | -35.8% | -10.3% | ||
| Q4 24 | 35.6% | -138.3% | ||
| Q3 24 | 18.0% | -63.9% | ||
| Q2 24 | -16.4% | -67.5% | ||
| Q1 24 | — | -41.2% |
每股收益（稀释后）PLXTPTA
| Q4 25 | $-0.06 | $-0.43 | ||
| Q3 25 | $0.03 | $-0.28 | ||
| Q2 25 | $0.00 | $-0.38 | ||
| Q1 25 | $-0.05 | $-0.05 | ||
| Q4 24 | $0.10 | $-0.65 | ||
| Q3 24 | $0.03 | $-0.32 | ||
| Q2 24 | $-0.03 | $-0.31 | ||
| Q1 24 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.7M | $33.2M |
| 总债务越低越好 | — | $178.9M |
| 股东权益账面价值 | $48.2M | $146.5M |
| 总资产 | $82.3M | $351.5M |
| 负债/权益比越低杠杆越低 | — | 1.22× |
8季度趋势，按日历期对齐
现金及短期投资PLXTPTA
| Q4 25 | $14.7M | $33.2M | ||
| Q3 25 | $13.6M | $17.4M | ||
| Q2 25 | $17.9M | $5.9M | ||
| Q1 25 | $19.5M | $11.9M | ||
| Q4 24 | $19.8M | $8.6M | ||
| Q3 24 | $27.4M | $21.2M | ||
| Q2 24 | $23.4M | $18.9M | ||
| Q1 24 | — | $17.9M |
总债务PLXTPTA
| Q4 25 | — | $178.9M | ||
| Q3 25 | — | $211.9M | ||
| Q2 25 | — | $260.2M | ||
| Q1 25 | — | $286.7M | ||
| Q4 24 | — | $326.1M | ||
| Q3 24 | — | $312.9M | ||
| Q2 24 | — | $383.8M | ||
| Q1 24 | — | $377.6M |
股东权益PLXTPTA
| Q4 25 | $48.2M | $146.5M | ||
| Q3 25 | $52.9M | $159.7M | ||
| Q2 25 | $49.9M | $168.5M | ||
| Q1 25 | $45.2M | $179.9M | ||
| Q4 24 | $43.2M | $185.7M | ||
| Q3 24 | $32.4M | $206.2M | ||
| Q2 24 | $28.6M | $218.6M | ||
| Q1 24 | — | $230.5M |
总资产PLXTPTA
| Q4 25 | $82.3M | $351.5M | ||
| Q3 25 | $82.3M | $398.1M | ||
| Q2 25 | $78.5M | $459.3M | ||
| Q1 25 | $73.9M | $495.2M | ||
| Q4 24 | $73.4M | $542.8M | ||
| Q3 24 | $61.6M | $546.8M | ||
| Q2 24 | $91.5M | $634.4M | ||
| Q1 24 | — | $640.2M |
负债/权益比PLXTPTA
| Q4 25 | — | 1.22× | ||
| Q3 25 | — | 1.33× | ||
| Q2 25 | — | 1.54× | ||
| Q1 25 | — | 1.59× | ||
| Q4 24 | — | 1.76× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 1.76× | ||
| Q1 24 | — | 1.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.0M | $1.9M |
| 自由现金流经营现金流 - 资本支出 | $1.6M | — |
| 自由现金流率自由现金流/营收 | 17.8% | — |
| 资本支出强度资本支出/营收 | 4.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.6M | — |
8季度趋势，按日历期对齐
经营现金流PLXTPTA
| Q4 25 | $2.0M | $1.9M | ||
| Q3 25 | $-3.7M | $-4.3M | ||
| Q2 25 | $-5.2M | $1.2M | ||
| Q1 25 | $-5.1M | $861.6K | ||
| Q4 24 | $4.0M | $-3.3M | ||
| Q3 24 | $4.1M | $1.7M | ||
| Q2 24 | $-3.6M | $-3.1M | ||
| Q1 24 | — | $-4.2M |
自由现金流PLXTPTA
| Q4 25 | $1.6M | — | ||
| Q3 25 | $-4.2M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $-3.8M | — | ||
| Q1 24 | — | — |
自由现金流率PLXTPTA
| Q4 25 | 17.8% | — | ||
| Q3 25 | -23.7% | — | ||
| Q2 25 | -36.2% | — | ||
| Q1 25 | -53.0% | — | ||
| Q4 24 | 19.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | -28.1% | — | ||
| Q1 24 | — | — |
资本支出强度PLXTPTA
| Q4 25 | 4.4% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 2.3% | 0.0% | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | — | — |
现金转化率PLXTPTA
| Q4 25 | — | — | ||
| Q3 25 | -1.58× | — | ||
| Q2 25 | -31.91× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
TPTA
暂无分部数据
